Showing results (111-120 of 150) with videos related to

Sort By:
Pageof 15
Frontiers in Pharmacology|October 12, 2023
Protective effect of heat-processed Gynostemma pentaphyllum on high fat diet-induced glucose metabolic disorders miceJin-Bo Xie, Peng Xie, Mei Guo, et al.
European Journal of Medicinal Chemistry|October 12, 2023
Discovery of dihydropyridinone derivative as a covalent EZH2 degraderBin Zhou, Beilei Wang, Fengming Zou, et al.
BMC Medicine|July 4, 2026
Efficacy of remote ischemic conditioning on cerebral blood flow regulation in patients with endovascular stenting: a randomized controlled trialYi-Ting Hou, Bao-Feng Xu, Huai-Mei Zhang, et al.
Signal Transduction and Targeted Therapy|January 15, 2023
Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignanciesHusheng Mei, Hong Wu, Jing Yang, et al.
Acta Pharmacologica Sinica|October 10, 2022
Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1Zuo-Wei Wang, Feng-Ming Zou, Ao-Li Wang, et al.
Addiction Biology|May 7, 2019
Neuronal HMGB1 in nucleus accumbens regulates cocaine reward memoryShuang-Qi Gao, Hai Zhang, Jin-Gang He, et al.
Journal of Natural Products|September 18, 2015
Aspertetranones A-D, Putative Meroterpenoids from the Marine Algal-Associated Fungus Aspergillus sp. ZL0-1b14Yuezhou Wang, Shuang Qi, Ying Zhan, et al.
Molecular Oncology|February 23, 2022
Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib-induced KIT mutations in gastrointestinal stromal tumoursJuan Liu, Jingjing Gao, Aoli Wang, et al.
Journal of Medicinal Chemistry|January 21, 2016
Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid LeukemiaXiaofei Liang, Xiaochuan Liu, Beilei Wang, et al.
Signal Transduction and Targeted Therapy|April 4, 2023
Discovery of IHMT-MST1-39 as a novel MST1 kinase inhibitor and AMPK activator for the treatment of diabetes mellitusJunjie Wang, Ziping Qi, Yun Wu, et al.
Pageof 15